FindTrial
Sign In

A Study on Stratification of Cervical Cancer Risk in HPV Positive Women

A Study on Stratification of Cervical Cancer Risk in HPV Positive Women

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043697
Enrollment
Unknown
Registered
2021-02-27
Start date
2022-03-01
Completion date
Unknown
Last updated
2023-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

case series:Nil

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
21 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. High-risk HPV (hrHPV) positive and cervical pathology LSIL; 2. With sexual history, no current pregnancy; 3. Aged 21 to 65 years; 4. Willing to participate and obey the regular follow-up until the end of the project.

Exclusion criteria

Exclusion criteria: 1. With history of ablation or excisional procedure for cervical dysplasia; 2. With prior hysterectomy, or prior pelvic radiation; 3. With autoimmune diseases or HIV infection, or currently taking immunosuppressants; 4. Currently participating in other research/projects.

Design outcomes

Primary

MeasureTime frame
p16(INK4a) cytology;High-risk HPV genotype;Cytology;High-risk HPV viral load;Histology;Host DNA methylation;Microbiome;—

Countries

China

Contacts

Public ContactHui Du

Peking University Shenzhen Hospital

duhui_107108@163.com+86 13923771052

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026